The Autologous Stem Cell Transplantation International Scleroderma ( ASTIS ) trial , a phase 3 , multicenter , randomized ( 1:1 ) , open-label , parallel-group , clinical trial conducted in 10 countries at 29 centers with access to a European Group for Blood and Marrow Transplantation-registered transplant facility .